News
GH
20.63
+14.87%
2.67
Does Guardant Health (NASDAQ:GH) Have A Healthy Balance Sheet?
Guardant Health, Inc. (NASDAQ:GH) has US$1.14b of debt, but has more cash than debt. The company uses debt to fund growth, but it has a healthy balance sheet. Guardant Health is showing 2 warning signs in our analysis of its use of debt. How risky is the company's use of Debt? We look at the balance sheet to see how the company is managing its debt.
Simply Wall St · 11h ago
Guardant Health Up Nearly 11%, on Pace for Largest Percent Increase Since May 2023 -- Data Talk
Guardant Health, Inc. (GH) is currently at $19.93, up $1.97 or 10.97%. Up three consecutive days; up 16.35% over this period. Down 88.87% from its all-time closing high of $179.10.
Dow Jones · 1d ago
REX American Resources Reports Upbeat Earnings, Joins Avalo Therapeutics, RH And Other Big Stocks Moving Higher On Thursday
REX American Resources Corporation shares jumped 23.2% to $54.15 after upbeat quarterly earnings. Avalo Therapeutics, Inc. Shares gained 430% in Thursday's session. The S&P 500 gained around 0.1% on Thursday. RH posted weaker-than-expected results for its fourth quarter.
Benzinga · 1d ago
Weekly Report: what happened at GH last week (0318-0322)?
Weekly Report · 4d ago
Guardant Health Revises Co-CEOs’ Compensation and Incentives
TipRanks · 03/22 21:22
Guardant Health: Shield Launch Could Drive Multiple Expansion
Guardant Health, Inc. (GH) has a competitive product in Shield that can gain a foothold in the colorectal cancer screening market. The company's stock is currently trading over 1.5 STD below historical discount to Exact Sciences. Guardant Health's Shield product is a blood-based screening test for early cancer. I believe there is 30% upside in the name from EV/Sales multiple expansion.
Seeking Alpha · 03/22 17:31
32 “Breakthroughs” stocks by BofA - Part 2
Tech 32 “Breakthroughs” stocks by BofA Securities published a list of 32 companies that its analysts believe will benefit from breakthroughs. These 32 stocks have a combined market cap of $16T. The list includes companies in the healthcare, communications, and energy sectors.
Seeking Alpha · 03/21 15:53
Insiders Buying Advance Auto Parts And 2 Other Stocks
U.S. Stocks closed higher on Tuesday. There were a few notable insider trades in Advance Auto Parts, Inc., Guardant Health and NB Bancorp. When insiders purchase shares, it indicates confidence in the company's prospects or that they view the stock as a bargain.
Benzinga · 03/20 13:02
Analysts’ Top Healthcare Picks: Compass Therapeutics (CMPX), Guardant Health (GH)
TipRanks · 03/19 06:30
Weekly Report: what happened at GH last week (0311-0315)?
Weekly Report · 03/18 09:28
Health Rounds: CAR-T therapy shows early promise against brain cancer
Health Rounds: CAR-T therapy shows early promise against brain cancer. A blood test for detecting colorectal cancer that was as accurate as current commercial home tests. Early trials hint at benefit ofCAR-T cells in glioblastoma. The therapy shrank tumors in three separate early-stage trials.
Reuters · 03/14 17:58
Buy Rating Affirmed for Guardant Health Amid Strong Shield Test Prospects and Positive ECLIPSE Study Results
TipRanks · 03/14 11:18
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Guardant Health (GH), Cue Health (HLTH) and Skye Bioscience (OtherSKYE)
TipRanks · 03/14 11:10
December 2025 Options Now Available For Guardant Health (GH)
NASDAQ · 03/12 15:11
Weekly Report: what happened at GH last week (0304-0308)?
Weekly Report · 03/11 09:27
Weekly Report: what happened at GH last week (0226-0301)?
Weekly Report · 03/04 09:28
New Survey: Patients and Physicians Overwhelmingly Agree Blood Tests Could Help Close the Colorectal Cancer Screening Gap
A new survey shows patients and physicians agree that blood-based testing could help close the colorectal cancer screening gap. More than 50 million eligible Americans are not up to date with recommended screenings. 90% of eligible Americans would be more likely to get screened with a blood test. A third of Americans are unaware they are behind in screening. 96% of all physicians surveyed would recommend an FDA-approved blood test to their patients.
Barchart · 03/01 04:30
BTIG Keeps Their Buy Rating on Guardant Health (GH)
TipRanks · 02/27 10:25
U.S. RESEARCH ROUNDUP-Agiliti, Domino's Pizza, Krystal Biotech
Wall Street analysts revise their ratings and price targets on several U.S. Listed companies. Agiliti, Domino's Pizza, Krystal Biotech, and Eli Lilly among companies with revised targets. Agilti cut to hold from buy, while others raise their targets.
Reuters · 02/27 07:31
Guardant Health Is Maintained at Overweight by Piper Sandler
Dow Jones · 02/26 15:01
More
Webull provides a variety of real-time GH stock news. You can receive the latest news about Guardant Health through multiple platforms. This information may help you make smarter investment decisions.
About GH
Guardant Health, Inc. is a precision oncology company focused on guarding wellness and giving every person more time free from cancer. It provides critical insights into what drives disease through its advanced blood and tissue tests, real-world data, and artificial intelligence (AI) analytics. Guardant tests help improve outcomes across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and helping doctors select the best treatment for patients with advanced cancer. For patients with advanced-stage cancer, it has developed Guardant360 laboratory developed test (LDT), and Guardant360 CDx, a comprehensive liquid biopsy test to provide tumor mutation profiling with solid tumors and to be used as a companion diagnostic in connection with non-small cell lung cancer (NSCLC), and breast cancer. It offers other tests, including Guardant360 TissueNext tissue test, Guardant Reveal blood test, Guardant360 Response blood test and others.